Abstract:The presence of ROS is a constant feature in living cells metabolizing O 2 . ROS concentration and compartmentation determine their physiological or pathological effects. ROS overproduction is a feature of cancer cells and plays several roles during the natural history of malignant tumor. ROS continuously contribute to each step of cancerogenesis, from the initiation to the malignant progression , acting directly or indirectly. In this review, we will (a) underline the role of ROS in the pathway leading a normal cell to tumor transformation and progression, (b) define the multiple roles of ROS during the natural history of a tumor, (c) conciliate many conflicting data about harmful or beneficial effects of ROS, (d) rethink the importance of oncogene and tumor suppressor gene mutations in relation to the malignant progression, and (e) collocate all the cancer hallmarks in a mechanistic sequence which could represent a “physiological” response to the initial growth of a transformed stem/pluripotent cell, defining also the role of ROS in each hallmark. We will provide a simplified sketch about the relationships between ROS and cancer. The attention will be focused on the contribution of ROS to the signaling of HIF, NF κ B, and Sirtuins as a leitmotif of cancer initiation and progression.

What problem does this paper attempt to address?

### Problems the paper attempts to solve This paper aims to explore the interactions among reactive oxygen species (ROS), hypoxia, inflammation and sirtuins in the initiation and progression of cancer. Specifically, the paper attempts to solve the following key problems: 1. **The role of ROS in the carcinogenesis process**: - **Cell transformation**: The paper explores how ROS induces gene mutations, leading to the transformation of normal cells into tumor cells. - **Growth promotion**: The paper analyzes how ROS promotes the growth and proliferation of transformed cells by increasing genomic instability. - **Malignant progression**: The paper discusses how ROS promotes the malignant progression of tumors at different stages of tumor development, such as under hypoxic conditions, by activating transcription factors such as HIF1α. 2. **Pleiotropic effects**: - **Reconciliation of harmful and beneficial effects**: The paper attempts to reconcile different data on whether ROS is harmful or beneficial to cells and explain its multiple roles under different conditions. - **The importance of gene mutations**: The paper re - thinks about the importance of oncogene and tumor suppressor gene mutations in malignant progression. 3. **The mechanistic sequence of cancer hallmarks**: - **The order of cancer hallmarks**: The paper attempts to place all cancer hallmarks in a mechanistic sequence to describe the "physiological" response from the initial growth of a transformed stem cell or totipotent cell to the formation of a malignant tumor. - **The role of ROS in each hallmark**: The paper details the specific role of ROS in each cancer hallmark. 4. **The contribution of signaling pathways**: - **Signaling of HIF, NF - κB and sirtuins**: The paper pays special attention to the central role of ROS in the signaling of HIF, NF - κB and sirtuins, which play key roles in the initiation and progression of cancer. ### Formula presentation - **Stabilization of HIF1α**: \[ \text{HIF1}\alpha+\text{ROS}\to\text{HIF1}\alpha_{\text{stable}} \] This formula indicates that ROS stabilizes HIF1α by inhibiting the activity of PHD (prolyl hydroxylase domain). - **ROS - induced DNA damage**: \[ \text{ROS}+\text{DNA}\to\text{DNA}_{\text{damage}} \] This formula indicates that ROS reacts with DNA, leading to DNA damage, which may trigger gene mutations. - **Expression of VEGF**: \[ \text{HIF1}\alpha\to\text{VEGF} \] This formula indicates that the activation of HIF1α leads to an increase in the expression of VEGF, promoting neovascularization. Through the exploration of these problems, the paper aims to provide a simplified relationship diagram showing the complex relationship between ROS and cancer and provide a new perspective for understanding the multi - step process of cancer.

The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression

ROS in cancer therapy: the bright side of the moon

Roles of Reactive Oxygen Species in Inflammation and Cancer

Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements

The role of ROS in tumour development and progression

Reactive Oxygen Species: A Key Constituent in Cancer Survival

Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells

Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the NADPH Oxidase NOX1–5 and Superoxide Dismutase 1–3 Signal Transduction Pathways

The double-edged roles of ROS in cancer prevention and therapy

ROS: A "booster" for chronic inflammation and tumor metastasis

Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment?

Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development

Modulation of reactive oxygen species in cancers: recent advances

Oxidative Stress in Cancer Cell Metabolism

Reactive Oxygen Species Mechanisms that Regulate Protein–Protein Interactions in Cancer

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy

MicroRNA and Oxidative Stress Interplay in the Context of Breast Cancer Pathogenesis

Oxidative Stress and Age-Related Tumors

A paradoxical role of reactive oxygen species in cancer signaling pathway: Physiology and pathology

Controlling Cancer Cells Using Reactive Oxygen Species

The Role of Oxidative Stress in Tumorigenesis and Progression